Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ovid Therapeutics Inc (NQ: OVID ) 0.7378 -0.0522 (-6.61%) Streaming Delayed Price Updated: 11:06 AM EDT, Jun 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 764,242 Open 0.7929 Bid (Size) 0.7300 (1) Ask (Size) 0.7400 (4) Prev. Close 0.7900 Today's Range 0.7000 - 0.7929 52wk Range 0.6903 - 4.139 Shares Outstanding 70,417,345 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Evaluating Ovid Therapeutics: Insights From 6 Financial Analysts June 18, 2024 Via Benzinga Nasdaq Surges Over 200 Points; Aaron's Shares Jump June 17, 2024 Via Benzinga Performance YTD -77.78% -77.78% 1 Month -75.81% -75.81% 3 Month -76.12% -76.12% 6 Month -78.24% -78.24% 1 Year -78.36% -78.36% More News Read More Is the Stock Market Closed on Juneteenth 2024? June 17, 2024 Via InvestorPlace ACHR Stock Alert: Archer Aviation Strikes New Deal With Signature Aviation June 17, 2024 Via InvestorPlace Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 17, 2024 Via Benzinga Cracking The Code: Understanding Analyst Reviews For Ovid Therapeutics May 07, 2024 Via Benzinga AAN Stock Alert: The Aaron’s Company Pops 33% on Take-Private Deal June 17, 2024 Via InvestorPlace Why Is Ovid Therapeutics (OVID) Stock Down 69% Today? June 17, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Monday's Intraday Session June 17, 2024 Via Benzinga Crude Oil Rises 1%; Mustang Bio Shares Spike Higher June 17, 2024 Via Benzinga Exposures Fossil Fuels US Stocks Mixed; Dow Tumbles Over 100 Points June 17, 2024 Via Benzinga Topics Stocks Exposures US Equities Recap: Ovid Therapeutics Q4 Earnings March 08, 2024 Via Benzinga What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail? June 17, 2024 Via Benzinga Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket June 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session June 17, 2024 Via Benzinga Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat June 17, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire 3 Sorry Penny Stocks to Sell in May While You Still Can May 28, 2024 Via InvestorPlace Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024 May 20, 2024 Via InvestorPlace OVID Stock Earnings: Ovid Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 14, 2024 Via InvestorPlace Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results May 14, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference May 13, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 24, 2024 Via Benzinga Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference April 04, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying March 21, 2024 Via Benzinga Topics Stocks Exposures US Equities Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results March 08, 2024 From Ovid Therapeutics Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
